Skip to main content
Sinphar Pharmaceutical Co., Ltd. logo

Sinphar Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,597 across all filing types
Latest filing 2025-06-19 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About Sinphar Pharmaceutical Co., Ltd.

https://www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
113年度股利金額(股東會決議)
Regulatory Filings
2025-06-19 Chinese
代重要子公司SUNETIC BIOTECH INC. 公告股東常會重要決議事項
Regulatory Filings
2025-06-19 Chinese
代重要子公司SUNETIC BIOTECH INC. 公告董事會公告決議股利分派事宜
Regulatory Filings
2025-06-19 Chinese
代重要子公司杏輝天力(杭州)藥業有限公司 公告決議股利分派事宜
Regulatory Filings
2025-06-19 Chinese
公告本公司董事會決議除息基準日等事宜
Regulatory Filings
2025-06-19 Chinese
公告本公司股東常會重要決議事項
Regulatory Filings
2025-06-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.